CASI Pharmaceuticals, Inc. to Participate in Two Upcoming September Conferences
CASI Pharmaceuticals has announced that its CEO, Dr. Wei-Wu He, will present at two virtual conferences in September 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CASI Pharmaceuticals has announced that its CEO, Dr. Wei-Wu He, will present at two virtual conferences in September 2020. The H.C. Wainwright 22nd Annual Global Investment Conference is scheduled for September 14 at 12:30 PM EDT, followed by the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 23 at 1:40 PM EDT. Webcasts will be accessible on the company's website, with archived replays available for 90 days. CASI Pharmaceuticals focuses on innovative therapeutics, especially in hematology and oncology in China and the U.S.
Details
News Market Reaction – CASI
The recorded move for CASI in the trading session of this news was +0.93%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKVILLE, Md. and BEIJING, Sept. 11, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that Dr. Wei-Wu He, Chairman and Chief Executive Officer of CASI Pharmaceuticals, will be presenting at the following upcoming virtual conferences in September. Details for the virtual conferences are as follows.
H.C. Wainwright 22nd Annual Global Investment Conference
Date: Monday, September 14th
Time: 12:30 PM (EDT)
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date: Wednesday, September 23rd
Time: 1:40 PM (EDT)
Webcast or external link of the company presentations will be available under "Events & Presentations" in the "Investors Relations" section of CASI's website. Archived replays will be available for approximately 90 days following the event.
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. ("CASI" or the "Company") is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the greater China market leveraging the Company's China-based regulatory and commercial competencies and its global drug development expertise. The Company's operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. ("CASI China"), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China. More information on CASI is available at www.casipharmaceuticals.com.
COMPANY CONTACT: CASI Pharmaceuticals, Inc. 240.864.2643 | INVESTOR CONTACT: Solebury Trout Jennifer Porcelli 646.378.2962 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/casi-pharmaceuticals-inc-to-participate-in-two-upcoming-september-conferences-301128032.html
SOURCE CASI Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.